COVID-19

News

scientifically visualization of a coronavirus spike protein

AZ, J&J tweaking COVID shots to reduce clotting risks; repor...

AstraZeneca and Johnson & Johnson are both exploring ways to modify their COVID-19 vaccines to minimise the risk of severe blood clotting reactions that are seen – albeit rarely – in so

News

FDA adds warning of rare neurological side effect to J&J COV...

The FDA has added a new warning on the Johnson & Johnson COVID-19 vaccine, saying the shot has been linked to a serious but rare side effect – Guillain-Barré syndrome – that can cause m

News

Clear COVID health information essential for a return to healthcare as normal

UK study raises hopes of long COVID test within months

A diagnostic test to detect long COVID could be available within six to 12 months, following the discovery that patients with the chronic condition have distinctive antibodies in their bloo

News

EMA finds possible link between mRNA COVID jabs and myocardi...

The EU medicines regulator has said that there is some evidence to suggest a possible link between mRNA-based vaccines for COVID-19 and rare cases of heart inflammation.

News

Eyeing delta surge, Pfizer will file COVID-19 booster next m...

With the COVID-19 delta variant becoming the dominant strain circulating in the US, Pfizer and BioNTech have said they will ask the FDA and other regulators to approve a third dose of their Comi

News

Gates Foundation backs COVID R&D at AI firm Exscientia

Artificial intelligence-based drug discovery company Exscientia is stepping up its search for new COVID-19 medicines, thanks to an award by the Bill & Melinda Gates Foundation.

AZ, J&J tweaking COVID shots to reduce clotting risks; repor...

FDA adds warning of rare neurological side effect to J&J COV...

UK study raises hopes of long COVID test within months

EMA finds possible link between mRNA COVID jabs and myocardi...

Eyeing delta surge, Pfizer will file COVID-19 booster next m...

Gates Foundation backs COVID R&D at AI firm Exscientia

Joint MHRA/NICE pathway 'benefits industry over patients'

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks